NEW YORK – July 2, 2021 – The Cardiovascular Research Foundation (CRF) announced that TVT 2021 will feature 12 studies as Late-Breaking Clinical Science. An annual meeting from CRF, TVT features cutting-edge research and techniques for structural heart interventions. TVT will take place online and in person, with limited attendance, at the Fontainebleau Miami Beach in Miami Beach, Florida July 20-22, 2021.
TVT’s late-breaking clinical science sessions will feature the latest research and innovations in TAVR, mitral, tricuspid and LAAO therapies. Expert commentary from world-renowned thought leaders in the field will also provide important context and perspective on these new and emerging treatments for patients with valvular heart disease.
The full agenda is now available online: https:/
Tuesday, July 20, 2021
Late-Breaking Clinical Science: TAVR I
7:00 AM – 8:00 AM ET
Moderators: Martin B. Leon, Allan Schwartz
Discussants: Eberhard Grube, Michael J. Reardon
Virtual Discussant: Jonathon A. Leipsic
Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis
John K. Forrest
The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk
Mathew Williams
Early neo2 Registry. Full Core-Lab Results of TAVI With the New Acurate neo2 Valve
Late-Breaking Clinical Science: Mitral I
7:00 AM – 8:00 AM ET
Moderator: Paul Sorajja, Gregg W. Stone
Virtual Discussants: David H. Adams, Federico M. Asch
Predictors of Reduction in Mitral Regurgitation by the MitraClip – Durable, Transient, or Failures in the COAPT Trial
Scott Lim
Impact of Timing of Surgery on Outcomes of Mitral Valve Surgery After Edge-to-Edge Transcatheter Mitral Repair: Results From The CUTTING-EDGE Registry
Thomas Modine
Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial
Gennaro Giustino
Wednesday, July 21, 2021
Late-Breaking Clinical Science: Mitral II
7:00 AM – 7:50 AM ET
Moderator: Patrick M. McCarthy, Allan Schwartz
Discussants: Isaac George, Paul A. Grayburn
Virtual Discussant: Howard C. Herrmann
Transapical Mitral Valve Implantation for Treatment of Symptomatic Mitral Valve Disease: A Real-world Multicenter Experience
Jörg Hausleiter
Impact of MAC on Patient Selection, Procedural Success and 1-Year Outcomes in a Real-World Patient Population Evaluated for TMVI: Results From the CHOICE-MI MAC Study
Walid Ben Ali
Contemporary Outcomes of TMVR With SAPIEN 3/Ultra for Failed Surgical Annuloplasty Rings in the US
Mayra Guerrero
Late-Breaking Clinical Science: Tricuspid and Left Atrial Appendage Closure
7:00 AM – 8:00 AM ET
Moderator: Susheel K. Kodali, Mark Reisman
Discussants: Vinayak N. Bapat, Matthew J. Price
Virtual Discussant: Rebecca T. Hahn
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System for Severe Tricuspid Regurgitation: A Multicenter, First-in-Human 1-Year Observation
Ming-yu (Anthony) Chuang
First Commercial Multicenter Experience With the PASCAL Transcatheter Valve Repair System for Tricuspid Regurgitation
Jörg Hausleiter
First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial
Saibal Kar
TVT 2021 will also feature 24 live cases from leading academic medical centers, 10 Master Class sessions focused on technique and procedural decision-making process, nine device-specific training opportunities, featured clinical research, and structural innovation sessions. For more than a decade, TVT has provided healthcare professionals with the latest advances, tools, and techniques for the treatment of valvular heart disease using nonsurgical procedures.
Additional information on TVT is available at https:/
HOW TO REGISTER:
Media may apply for remote press registration by emailing jromero@crf.org.
###
About CRF
The Cardiovascular Research Foundation (CRF) is one of the world’s leading nonprofit organizations specializing in interventional cardiology innovation, research, and education. CRF is dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 30 years, CRF has helped accelerate medical breakthroughs and educated doctors on the latest treatments for heart disease. CRF’s centers of excellence include the CRF Skirball Center for Innovation, CRF Clinical Trials Center, CRF Center for Education, CRF Digital, TCTMD, and Structural Heart: The Journal of the Heart Team. For more information, visit http://www.
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
